Company Profiles

driven by the PitchBook Platform

Saladax Biomedical

Saladax Biomedical
2004 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
$22.9M LATEST DEAL AMOUNT
Description

Provider of guided chemotherapy dosing designed to develop convenient and cost-effective blood tests for personalized chemotherapeutic dosing. The company's chemotherapy dosing increases the impact of personalized medicine, enabling physicians to optimize drug dosing to meet individual patient needs.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 116 Research Drive
  • Bethlehem, PA 18015
  • United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Saladax Biomedical’s full profile, request a free trial.

Saladax Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 05-Sep-2013 $22.9M 000.00 000.00 Completed Generating Revenue
6. Debt - General 22-Jul-2013 0000 000.00 Completed Generating Revenue
5. Debt - General 21-Jun-2011 000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 05-Mar-2010 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 05-Oct-2009 000 000.00 0000 Completed Startup
2. Early Stage VC (Series A) 18-Aug-2008 $3.57M $7.33M Completed Startup
1. Early Stage VC 12-Dec-2007 $3.76M $3.76M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Saladax Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.00 00.00 00.00 00 00.00 00.000
Series A 1,606,624 $2.22 $2.22 1x $2.22 8.03%
To view this company’s complete Cap Table, request access »

Saladax Biomedical Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ben Franklin Technology Partners of Northeastern Pennsylvania Lender/Debt Provider Minority 000 0000 000000 0
Columbia Ventures PE/Buyout Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group Minority 000 0000 000000 0
Excel Venture Management Venture Capital Minority 000 0000 000000 0
Golden Seeds Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Saladax Biomedical Executive Team (13)

Name Title Board
Seat
Contact
Info
Salvatore Salamone Ph.D Co-Founder, President, Board Member and Chief Executive Officer
Adrienne Choma JD Co-Founder
Irina Baburina Ph.D Vice President, Research & Development and Operations

10 Former Executives

You’re viewing 3 of 13 executives. Get the full list »